Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (263)
- Legislation (86)
- COVID-19 (66)
- Compliance and enforcement (56)
- Vaping hub (48)
- Manufacturing (31)
- Import and export (24)
- Labelling and packaging (21)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (15)
- Weight loss products (7)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
720 result(s) found, displaying 601 to 625
-
Media releasesThe TGA has seized black salve products after executing a search warrant at a business premises on the Gold Coast
-
Media releasesCourt action continues against Peptide Clinics Australia for alleged advertising breaches
-
Media releasesTGA data analysis
-
Media releasesSecond candidate in international work-share initiative
-
Media releasesInvitation to comment on discussion paper now published
-
Update to the advertising complaints and investigation information database improves search features
Media releasesThis update implements feedback from stakeholders to make the database more user-friendly -
Regulatory decision noticesDirection Notice issued to cease advertisement of prescription and illegal products
-
Media releasesThe TGA is alerting consumers to the potential risks of purchasing electronic cigarette liquid
-
Media releasesDealing countefeit and unapproved medicines is a serious offence as shown in recent TGA prosecution outcome in South Australia
-
Media releasesThis legal action follows an investigation by the Therapeutic Goods Administration
-
Regulatory decision noticesTGO 100 has been registered on the Federal Register of Legislation. It commences on 8 December 2018, repealing and replacing TGO 98
-
Media releasesThere will not be a decision announced on scheduling of alkyl nitrites on 29 November 2018. Further public consultation will be undertaken.
-
Media releasesJoint media release between Australian Border Force and Therapeutic Goods Administration
-
Media releasesThe TGA has launched a web hub to help consumers and health professionals find information on transvaginal (urogynaecological) surgical mesh.
-
Regulatory decision noticesTGA issues advertising direction
-
Media releasesToday we celebrate the official launch of the TGA Facebook page
-
Media releasesOur annual survey measures satisfaction with a range of services and activities including our role and performance
-
Media releasesApalutamide (Erlyand) is the first medicine approved via ACSS Consortium’s NCE working group
-
Media releasesConsumers can now report dodgy ads for medicines and medical devices through a single online form
-
Regulatory decision noticesThis instrument applies to an application to list a complementary medicine under section 26AE of the Act.
-
Regulatory decision noticesThis instrument applies to an application to list a medicine under section 26 or 26A of the Act.
-
Regulatory decision noticesThis instrument applies to an application to register a complementary medicine
-
Regulatory decision noticesTherapeutic Goods (Provisional Determinations and Orphan Drug Designations-Extension) Approval of Application Form.
-
Regulatory decision noticesThis instrument applies to the online form titled Prescription Medicines Designation/Determination Application in the TGA's electronic lodgement facility, completed in accordance with the relevant instructions in that form.
-
Media releasesInformation about influenza vaccines for use in 2018